LEP and Anorexia: The co-administration of leptin and SHU9119 (a synthetic antagonist of both MCR3 and MCR4 receptors), attenuated leptin-induced anorexia [260] and completely inhibited leptin-induced BAT increase in UCP1 mRNA levels [225,261].